RECRUITINGOBSERVATIONAL
Liquid Biospy for Urinary Cancers
Use of Urinary Tumor Cells and Circulating Tumor Cells (CTCs) in the Prognosis and Therapy of Patients With Bladder (BCa) and Upper Urinary Tract (UTUC) Cancer"
About This Trial
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.
Who May Be Eligible (Plain English)
Who May Qualify:
Diagnosis of urothelial neoplasia, naive for therapy
Who Should NOT Join This Trial:
Absence of previous neolpastic disease or genetic diseases
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Diagnosis of urothelial neoplasia, naive for therapy
Exclusion Criteria:
Absence of previous neolpastic disease or genetic diseases
Treatments Being Tested
GENETIC
Genetic analysis on isolated cells
Isolation of cells from blood and urine
Locations (1)
Urology Department
Milan, Italy